Study
Chronic myelomonocytic leukemia
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001005107 | Other |
Study Description
Chronic myelomonocytic leukemia is an aggressive hematological malignancy with dismal outcomes, with the pCMML subtype in particular having median OS of <2 years and high rates of AML transformation (Patnaik et al., 2014). Given limited therapeutic options for affected patients, we carried out this study to define the genetic and epigenetic landscape of pCMML and identify therapies that could modify disease biology.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001007026 |
106 Whole Exom Sequencing (WXS) of CMML samples. Paired-end fastq are provided.
|
Illumina HiSeq 2500 | 106 |
Who archives the data?
Publications
Citations
Retrieving...
Retrieving...
